Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Comment by Breakthoroughon Mar 17, 2021 2:44pm
156 Views
Post# 32818043

RE:RE:RE:RE:If the tree falls in the forest...

RE:RE:RE:RE:If the tree falls in the forest... And also to this one. It says the PDL-1 expression (potential biomarker as in Linfoma) has to be explored in NSCLC patients. May be there is still room for a different trial in NSCLC, we cannot know till there are data: Tom Shrader Okay. And really the same question for the non-small cell cohort that didnt work. I mean people are kind of finding that to add to PD-1, you really have to find a place where PD-1 works well. So were all those patients significantly PD-L1 positive in that cohort? Joanne Schindler So this is Joanne again. That is information that were pulling in now. So well have more information about that in the future. As you can imagine, lot of dataset that we need to go through and to better understand these results.
<< Previous
Bullboard Posts
Next >>